The future of lymphoma treatment – combining new therapies with molecular diagnosis
Developments in prognostic factors of acute myeloid leukemia (AML)
Gert J. Ossenkoppele
Can ibrutinib be used as a first-line treatment in CLL?
The utility of next-generation sequencing for multiple myeloma
Chng Wee Joo
Topics in multiple myeloma discussed at ASCO 2016